Cargando…
Impact of renin-angiotensin system inhibitors on the survival of patients with rectal cancer
BACKGROUND: Renin-angiotensin system inhibitors (RASIs) are widely used in the treatment of hypertension. However, their impact on the outcome of the combined treatment of rectal cancer is poorly understood. The aim of this study was to assess the effect of RASIs on the survival of rectal cancer pat...
Autores principales: | Zeman, Marcin, Skałba, Władysław, Wilk, Agata Małgorzata, Cortez, Alexander Jorge, Maciejewski, Adam, Czarniecka, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316329/ https://www.ncbi.nlm.nih.gov/pubmed/35879682 http://dx.doi.org/10.1186/s12885-022-09919-0 |
Ejemplares similares
-
Risk factors for long-term survival in patients with ypN+ M0 rectal cancer after radical anterior resection
por: Zeman, Marcin, et al.
Publicado: (2022) -
The assessment of risk factors for long-term survival outcome in ypN0 patients with rectal cancer after neoadjuvant therapy and radical anterior resection
por: Zeman, Marcin, et al.
Publicado: (2021) -
Assessment of the risk of permanent stoma after low anterior resection in rectal cancer patients
por: Zeman, Marcin, et al.
Publicado: (2020) -
Treatment of Oesophagojejunostomy Leakage With the Use of Fibrin Glue: Case Report
por: Skałba, Władysław, et al.
Publicado: (2022) -
Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)